Naturally Selected CD7 CAR-T Therapy without Genetic Manipulations for T-ALL/LBL: First-in-human Phase I Clinical Trial.
Blood. 2022 May 2:blood.2021014498. doi: 10.1182/blood.2021014498. Online ahead of print.
Blood. 2022.
PMID: 35500125